Structure: Transcription & Translation Evaluations
To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.
Sign in | Free Trial | Subscribe | Recommend to Library
New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.
SECTION HEADS
-
Gene Center Munich and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany
-
Structural and Computational Biology Programme, The European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
-
Department of Biophysics, Johns Hopkins Medical Institute, Baltimore, MD, USA
Section Topics
- » Chromatin-modifying enzymes
- » DNA structure
- » DNA-modifying enzymes
- » Nucleosomes & chromatin
- » RNA polymerases
- » Ribosomes
- » SRP & translocons
- » Transcription factors
- » Transcriptional regulators
- » mRNA processing
- » tRNA synthetases
LATEST EVALUATION
Scott K Silverman, University of Illinois at Urbana-Champaign, USA. F1000 Structural Biology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
2 Evaluations, most recent by
Stephen Woski, University of Alabama, USA. F1000 Chemical Biology
- New Finding
- Interesting Hypothesis
- Controversial
INDIVIDUALS
Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.
Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.
RECOMMENDATIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
LIBRARIANS & INFORMATION MANAGERS
Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.
FREE ACCESS
Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
